Analyst Price Targets — LKFT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 10, 2026 9:29 am | — | Morgan Stanley | $30.00 | $30.59 | TheFly | Lakefront Biotherapeutics resumed with an Equal Weight at Morgan Stanley |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for LKFT

Mechelen, Belgium; 14 July 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") announces that it has repurchased 108,645 Lakefront shares between 06 July 2026 and 10 July 2026, as follows: Date of purchase Market/MTF Number of shares Average price paid (€) Total (€) Lowest price paid (€)…

Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext and NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research and Development Pharma at Sanofi SA, Dr. Paulo Fontoura has tendered his resignation from the Board of Directors.

Mechelen, België; 13 juli 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext and NASDAQ: LKFT) heeft vandaag bekendgemaakt dat dr. Paulo Fontoura, na zijn benoeming tot Executive Vice President en Global Head of Research and Development Pharma bij Sanofi SA, zijn mandaat als lid van de Raad van Bestuur heeft neergelegd. "Ik wil Paulo feliciteren met deze belangrijke benoeming en hem oprecht bedanken voor zijn…

Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo Fontoura has tendered his resignation from the Board of Directors.

Mechelen, Belgium; 07 July 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") announces that it has repurchased 104,022 Lakefront shares between 29 June 2026 and 03 July 2026, as follows: Date of purchase Market/MTF Number of shares Average price paid (€) Total (€) Lowest price paid (€)…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for LKFT.
Senate Trading
No Senate trades found for LKFT.
U.S. House Trading
No House trades found for LKFT.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
